Who
James Sapirstein
Director
Company insider
Files Form 4 as: Director, INmune Bio; Chief Executive Officer, Cocrystal Pharma; Director, ZyVersa Therapeutics; Director, Onconetix; Chairman and CEO, GridAI Technologies; Director, Lunai Bioworks; Interim CEO, Marizyme; Chief Executive Officer, Hepion Pharmaceuticals.
In numbers
- Trades disclosed
- 60
- Buys
- 3
- Sells
- 7
- Bought
- $15K
- Sold
- $26K
- Companies
- 11
- Companies where not an officer
- 6
- First trade
- 8 Nov 2012
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | INMB INmune Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | INMB INmune Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 3 Jun 2026filed 3 Jun 2026 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,000 at $0.00 | filing |
| 3 Jun 2026filed 3 Jun 2026 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,000 at $0.00 | filing |
| 11 Jul 2025filed 15 Jul 2025 | ZyVersa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,066 at $0.00 | filing |
| 26 Sep 2024filed 30 Sep 2024 | ONCO OnconetixBiotechnology | SEC FORM 4 Code A | —3,318 at $0.00 | filing |
| 2 Jul 2024filed 3 Jul 2024 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $1,3791,289 at $1.07 | filing |
| 25 Jun 2024filed 27 Jun 2024 | LNAI Lunai Bioworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,137 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $736174 at $4.23 | filing |
| 15 Mar 2024filed 19 Mar 2024 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $9,3601,887 at $4.96 | filing |
| 6 Mar 2024filed 19 Mar 2024 | LNAI Lunai Bioworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,196 at $0.00 | filing |
| 12 Jan 2024filed 17 Jan 2024 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $697166 at $4.20 | filing |
| 2 Jan 2024filed 3 Jan 2024 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 29 Dec 2023filed 3 Jan 2024 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Code A | —17,660 at $0.00 | filing |
| 4 Oct 2023filed 6 Oct 2023 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $8022,764 at $0.29 | filing |
| 3 Jul 2023filed 5 Jul 2023 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $5,1573,349 at $1.54 | filing |
| 31 May 2023filed 1 Jun 2023 | ONCO OnconetixBiotechnology | SEC FORM 4 Code A | —6,360 at $0.00 | filing |
| 24 May 2023filed 18 Jul 2024 | ZyVersa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —132 at $0.00 | filing |
| 3 Apr 2023filed 5 Apr 2023 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Sold | $8,3683,347 at $2.50 | filing |
| 6 Mar 2023filed 4 Apr 2023 | LNAI Lunai Bioworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —64,655 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.